US · Healthcare · Drug Manufacturers - General
EPS came in at -0.54 against a street estimate of -0.23 — a miss of 134.8%.
with an average price target of $19.67.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nasus Pharma Ltd. — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.